Research shows muscularis macrophages in the gut trigger α-synuclein misfolding in Parkinson’s disease, spreading to the brain via immune pathways, with potential for early intervention through...
Life Biosciences receives FDA clearance for the first human trial of cellular reprogramming targeting glaucoma and NAION, signaling regulatory openness to longevity therapies and potential vision rest...
Analytical exploration of how geroscience, epigenetic reprogramming, and AI-driven therapies are converging to extend healthspan, with insights on clinical trials, societal impacts, and future trends....
A Nature Aging study shows mitochondrial stress enhances senolytic drugs like navitoclax, improving senescent cell removal by 40% with metabolic interventions. New research reveals mitochondrial stres...
Recent neuroscience studies reveal that functional amyloids, regulated by chaperone proteins, are essential for long-term memory, challenging traditional views and offering new therapeutic avenues for...
The FDA has greenlit the first human trial of ER-100, a partial epigenetic reprogramming therapy targeting age-related eye diseases, marking a pivotal step in anti-aging and regenerative medicine. A l...
Analytical post on the rise of digital detoxes and mindfulness apps, exploring their role in stress reduction, productivity gains, and the risks of screen dependency, with expert insights and real-wor...
Personalized nutrition, powered by AI and genomics, is transforming health outcomes with data-driven diets. This post explores benefits, access tips, and socioeconomic challenges. Advancements in AI a...
New research connects excessive screen time to mental health issues and physical strain, highlighting benefits from structured digital breaks and corporate accountability in tech design. Recent studie...
Advancements in genetic testing and AI enable tailored nutrition plans, improving health outcomes and adherence based on individual DNA profiles and real-time data. New AI and genomics tools are trans...
